Advertisement

Systemic Vasculitis Syndromes

  • Jerry C. Jacobs

Abstract

Vasculitis, inflammation in and around the blood vessels, which is sometimes associated with fibrinoid necrosis, may be seen in many of the conditions discussed in this book. In most rheumatic diseases, vasculitis is only one feature of a well-defined, complex, pathologic process (Fig. 7.1), and the disease (e.g., SLE or dermatomyositis) is best characterized by other distinctive diagnostic clinical and laboratory features. However, in the diverse and perhaps totally unrelated syndromes discussed in this chapter, vasculitis itself is the predominant pathologic process, and the clinical manifestations are primarily a direct result of the damage to the blood vessels (Table 7.1).

Keywords

Kawasaki Disease Systemic Vasculitis Polyarteritis Nodosa Toxic Shock Syndrome Coronary Artery Aneurysm 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Fâuci AS, Haynes BF, Katz P: The spectrum of vasculitis: Clinical, pathologic immunologic and therapeutic considerations. Ann Intern Med 89 (part 1 ): 660676, 1978.Google Scholar
  2. 1a.
    LeRoy EC (Ed): Systemic Vasculitis: The Biologic Basis. Marcel Dekker, New York, 1992.Google Scholar
  3. 2.
    Churg A, Churg J (Eds): Systemic Vasculitides. Igaku-Shoin. New York, 1991.Google Scholar
  4. 3.
    Hearth-Holmes M, Zahradka SL, Baethge BA, Wolf RE: Leukocytoclastic vasculitis associated with hepatitis C. Am J Med 90: 765–766, 1991.PubMedGoogle Scholar
  5. 4.
    Levy M: Severe deficiency of alpha 1-antitrypsin associated with cutaneous vasculitis, rapidly progressive glomerulonephritis, and colitis. Am J Med 81: 363, 1986.PubMedGoogle Scholar
  6. 5.
    Liang MH, Stern S, Fortin PR, et al.: Fatal pulmonary venoocclusive disease secondary to a generalized venulopathy: a new syndrome presenting with facial swelling and pericardial tamponade. Arthritis Rheum 34: 228–233, 1991.PubMedGoogle Scholar
  7. 6.
    Yanagawa H, Kawasaki T, Shigematsu I: Nationwide survey on Kawasaki disease in Japan. Pediatrics 80: 58–62, 1987.PubMedGoogle Scholar
  8. 7.
    Taubert KA, Rowley AH, Shulman ST: A seven year (1984–1990) U.S. Nationwide hospital survey of Kawasaki disease. Pediatr Research 31 #4 Pt 2: 102A, 1992.Google Scholar
  9. a.Kim JJ, Donalds JS, Corydon KE, Shulman ST: Lymphadenitis as dominant presenting manifestation of Kawasaki disease. Pediatr Research 31 #4 Pt 2: 123A, 1992.Google Scholar
  10. 8.
    Friter BS, Lucky AW: The perineal eruption of Kawasaki syndrome. Arch Dermatol 124: 1805–1810, 1988.PubMedGoogle Scholar
  11. 9.
    Kawasaki T: Infectious disease (Japan) 7:19–32, 1977; an abstract of the diagnostic guidelines in English and color photographs are available from the Kawasaki Disease Research Information Center; Hosaka Bldg., 1–10 KandaOgawamachi; Chiyoda-ku; Tokyo 101 Japan.Google Scholar
  12. 10.
    Melish ME, Hicks RM, Larson EJ: Mucocutaneous lymph node syndrome in the United States. Am J Dis Child 130: 599–607, 1976.PubMedGoogle Scholar
  13. 11.
    Kawasaki T, Kosaki F, Okawa S, et al.: A new infantile acute febrile mucocutaneous lymph node syndrome prevailing in Japan. Pediatrics 54: 271–281, 1974.PubMedGoogle Scholar
  14. 12.
    Kawasaki disease-it’s official and it’s here. Med World News 18 (December 12): 57–69, 1977.Google Scholar
  15. 13.
    A look at mucocutaneous lymph node syndrome. Consultant 18 (March): 6061, 1978.Google Scholar
  16. 14.
    Fetterman GH, Hashida Y: Mucocutaneous lymph node syndrome: a disease widespread in Japan which demands our attention. Pediatrics 54: 268–270, 1974.PubMedGoogle Scholar
  17. 15.
    Bures FA: Beau’s lines in mucocutaneous lymph node syndrome. Am J Dis Child 135: 383, 1981.PubMedGoogle Scholar
  18. 16.
    Sato K, Ouchi K, Taki M: Yersinia pseudotuberculosis infection in children, resembling lzumi fever and Kawasaki syndrome. Pediatr Infect Dis 2:123–126, 1983 (see also correspondence on p. 494).Google Scholar
  19. 17.
    Hurvitz H, Branski D, Gross-Kieselstein E, et al.: Acetaminophen hypersensitivity resembling Kawasaki disease. Israel J Med Sci 20: 145–147, 1984.PubMedGoogle Scholar
  20. 18.
    Burns JC, Wiggin JW Jr, Toews WH, et al.: Clinical spectrum of Kawasaki disease in infants younger than 6 months of age. J Pediatr 109: 759–763, 1986.PubMedGoogle Scholar
  21. 19.
    Rowley AH, Gonzalez-Crussi F, Gidding SS, et al.: Incomplete Kawasaki disease with coronary artery involvement. J Pediatr 110: 409–413, 1987.PubMedGoogle Scholar
  22. 20.
    McCowen C, Henderson DC: Sudden death in incomplete Kawasaki’s disease. Arch Dis Child 63: 1254–1271, 1988.PubMedGoogle Scholar
  23. 21.
    Kohr RM: Progressive asymptomatic coronary artery disease as a late fatal sequela of Kawasaki disease. J Pediatr 108: 256–259, 1990.Google Scholar
  24. 22.
    Chan KW, Kaikov Y, Wadsworth LD: Thrombocytosis in childhood: A survey of 94 patients. Pediatrics 84: 1064–1067, 1989.PubMedGoogle Scholar
  25. 23.
    Byard RW, Edmonds JF, Silverman E, Silver MM: Respiratory distress and fever in a 2-month old infant. J Pediatr 118: 306–313, 1991.PubMedGoogle Scholar
  26. 24.
    Kitamura S, Kawashima Y, Kawachi K, et al.: Left ventricular function in patients with coronary arteritis due to acute febrile mucocutaneous lymph node syndrome or related diseases. Am J Cardiol 40: 156–164, 1977.PubMedGoogle Scholar
  27. 25.
    Tanaka N, Semimoto K, Fukushima T, et al.: Pathological study of fatal MCLS: relationship with infantile periarteritis nodosa. In Shiokawa Y (ed.) Vascular Lesions of Collagen Diseases and Related Conditions. University Park Press, Baltimore, 1977, pp. 296–307.Google Scholar
  28. 26.
    Landing BH, Larson EJ: Are infantile periarteritis nodosa with coronary artery involvement and fatal, mucocutaneous lymph node syndrome the same? Comparison of 20 patients from North America with patients from Hawaii and Japan. Pediatrics 59: 651–662, 1977.PubMedGoogle Scholar
  29. 27.
    Fujiwara H, Hamashima Y: Pathology of the heart in Kawasaki disease. Pediatrics 61: 100–107, 1978.PubMedGoogle Scholar
  30. 28.
    Fukushige J, Nihill MR, McNamara DG: Spectrum of cardiovascular lesions in mucocutaneous lymph node syndrome; analysis of eight cases. Am J Cardiol 45: 98–107, 1980.PubMedGoogle Scholar
  31. 29.
    Onouchi Z, Tomizawa N, Goto M, et al.: Cardiac involvement and prognosis in acute mucocutaneous lymph node syndrome. Chest 68: 297–301, 1975.PubMedGoogle Scholar
  32. 30.
    Yutani C, Go S, Kamiya T, et al.: Cardiac biopsy in Kawasaki disease. Arch Pathol Lab Med 105: 470–473, 1981.PubMedGoogle Scholar
  33. 31.
    Westphalen MA, McGrath MA, Kelly W, et al.: Kawasaki disease with severe peripheral ischemia: treatment with prostaglandin E1 infusion. J Pediatr 112: 431–433, 1988.PubMedGoogle Scholar
  34. 32.
    Masuda H, Shozawa T, Naoe S, Tanaka N: The intercostal artery in Kawasaki disease: a pathologic study of 17 autopsy cases. Arch Pathol Lab Med 110: 1136–1142, 1986.PubMedGoogle Scholar
  35. 33.
    Fujiwara T, Fujiwara H, Nakano H: Pathological features of coronary arteries in children with Kawasaki disease in which coronary arterial aneurysm was absent at autopsy. Quantitative Analysis. Circulation 78: 345–350, 1988.PubMedGoogle Scholar
  36. 34.
    Tanaka N, Naoe S, Masuda H, Ueno T: Pathological study of sequelae of Kawasaki disease (MCLS) with special reference to the heart and coronary arterial lesions. Acta Pathol Jpn 36: 1513–1527, 1986.PubMedGoogle Scholar
  37. 35.
    Sasaguri Y, Kato H: Regression of aneurysms in Kawasaki disease: a pathological study. J Pediatr 100: 225–231, 1982.PubMedGoogle Scholar
  38. 36.
    Kegel SM, Dorsey TJ, Rowen M, et al.: Cardiac death in mucocutaneous lymph node syndrome. Am J Cardiol 40: 282–286, 1977.PubMedGoogle Scholar
  39. 37.
    Larson EJ: Comparative pathology of vasculitis: natural occurrence in lower animals. In Shiokawa Y (ed.) Vascular Lesions of Collagen Diseases and Related Conditions. University Park Press, Baltimore, 1977, pp. 347–355.Google Scholar
  40. 38.
    Lehman TJA, Warren R, Gietl D, et al.: Variable expression of lactobacillus casei cell wall-induced coronary arteritis: an animal model of Kawasaki’s disease in selected inbred mouse strains. Clin Immunol Immunopathol 48: 109–118, 1988.Google Scholar
  41. 39.
    Leung DY-M: New developments in Kawasaki disease. Curr Opin Rheum 3: 46–55, 1990.Google Scholar
  42. 40.
    Kato S, Kimura M, Tsuji K, et al.: HLA anigens in Kawasaki disease. Pediatrics 61: 252–255, 1978.PubMedGoogle Scholar
  43. 41.
    Krensky AM, Berenberg W, Shanley K, et al.: HLA antigens in mucocutaneous lymph node syndrome in New England. Pediatrics 67: 741–743, 1981.PubMedGoogle Scholar
  44. 42.
    Fujita Y, Nakamura Y, Sakata K, et al.: Kawasaki disease in families. Pediatrics 84: 666–669, 1989.PubMedGoogle Scholar
  45. 43.
    Daniels SR, Specker B: Association of rug shampooing and Kawasaki disease. J Ped 118: 485–488, 1991.Google Scholar
  46. 44.
    Jacobs JC: Salicylate treatment of epidemic Kawasaki disease in New York City. Ther Drug Monitor 1: 123–130, 1979.Google Scholar
  47. 45.
    Rauch AM, Kaplan SL, Nihill MR, et al.: Kawasaki syndrome clusters in Harris County, Texas, and Eastern North Carolina. A high endemic rate and a new environmental risk factor. Am J Dis Child 142: 441–444, 1988.PubMedGoogle Scholar
  48. 46.
    Fatica NS, Ichida F, Engle MA, Lesser ML: Rug shampoo and Kawasaki disease. Pediatrics 84: 231–234, 1989.PubMedGoogle Scholar
  49. 47.
    Rauch AM, Glode MP, Wiggins JW Jr., et al.: Outbreak of Kawasaki syndrome in Denver, Colorado: association with rug and carpet cleaning. Pediatrics 87: 664–669, 1991.Google Scholar
  50. 48.
    Burns JC, Mason WH, Glode MP, et al.: Clinical and epidemiologic characteristics of patients referred for evaluation of possible Kawasaki disease. J Pediatr 118: 680–686, 1991.PubMedGoogle Scholar
  51. 49.
    Bell DM, Brink EW, Nitzkin JL, et al.: Kawasaki syndrome: description of two outbreaks in the United States. N Engl J Med 304: 1568–1575, 1981.PubMedGoogle Scholar
  52. 50.
    Jacobs JC: Asai score system. J Thorac Cardiovasc Surg 87: 149, 1984.PubMedGoogle Scholar
  53. 51.
    Ichida F, Fatica NS, O’Loughlin JE, et al.: Correlation of electrocardiographic and echocardiographic changes in Kawasaki syndrome. Am Heart J 116: 812, 1988.PubMedGoogle Scholar
  54. 52.
    Nakano H, Ueda K, Saito A, et al.: Scoring method for identifying patients with Kawasaki disease at high risk of coronary artery aneurysms. Am J Cardiol 58: 739–742, 1986.PubMedGoogle Scholar
  55. 53.
    Chung KJ, Rinaldi RE, Fulton DR, et al.: Cardiac involvement with Kawasaki disease in children from New England, abstracted. Am J Cardiol 47: 457, 1981.Google Scholar
  56. 54.
    Chusid MJ, Tang TT: Fever, diarrhea, anemia, rash, and acrocyanosis in a 2-month-old girl. J Pediatr 93: 1052–1057, 1978.PubMedGoogle Scholar
  57. 55.
    Diller L, Newburger JW, Burns JC: Characterization of the anemia in Kawasaki disease (KD) patients (Pts). Pediatr Res 25S: 177A, 1989.Google Scholar
  58. 56.
    Ishiguro N, Takahashi Y: Kawasaki disease associated with idiopathic thrombocytopenic purpura. Eur J Pediatr 148: 379, 1989.PubMedGoogle Scholar
  59. 57.
    Hara T, Mizuno Y, Akeda H, et al.: Thrombocytopenia: a complication of Kawasaki disease. Eur J Pediatr 147: 51–53, 1988.PubMedGoogle Scholar
  60. 58.
    Magilavy DB, Speert DP, Silver TM, et al.: Mucocutaneous lymph node syndrome: report of two cases complicated by gallbladder hydrops and diagnosed by ultrasound. Pediatrics 61: 699–702, 1978.PubMedGoogle Scholar
  61. 58a.
    a.Bader-Meunier B, Hadchouel M, Fabre M, et al.: Intrahepatic bile duct damage in children with Kawasaki disease. J Pediatr 120: 750–752, 1992.PubMedGoogle Scholar
  62. 59.
    Franken EA Jr, Kleiman MB, Norins AL, et al.: Intestinal pseudo-obstruction in mucocutaneous lymph-node syndrome. Radiology 130: 649–651, 1979.PubMedGoogle Scholar
  63. 60.
    Mercer S, Carpenter B: Surgical complications of Kawasaki disease. J Pediatr Surg 16: 444–448, 1981.PubMedGoogle Scholar
  64. 61.
    Murphy DJ Jr, Morrow R, Harberg FJ, Hawkins EP: Small bowel obstruction as a complication of Kawasaki disease. Clin Pediatr 26: 193–195, 1987.Google Scholar
  65. 62.
    Stoler J, Biller JA, Grand RJ: Pancreatitis in Kawasaki disease. Am J Dis Child 141: 306–308, 1987.PubMedGoogle Scholar
  66. 63.
    Yanagitani Y, Fujita M: Avascular necrosis of the femoral head associated with mucocutaneous lymph node syndrome. J Ped Orthop 6: 107–109, 1986.Google Scholar
  67. 64.
    Sundel RP, Newburger JW, McGill T, et al.: Sensorineural hearing loss associated with Kawasaki disease. J Pediatr 117: 371–377, 1990.PubMedGoogle Scholar
  68. 65.
    Haslam RHA, Cochrane D, Amundson GM, et al.: Neurotoxic complications of contrast computed tomography in children. J Pediatr 111: 837–840, 1987.PubMedGoogle Scholar
  69. 65a.
    a.Kazi A, Gauthier M, Lebel MH, et al.: Uvulitis and supraglottitis: Early manifestations of Kawasaki disease. J Pediatr 120: 564–567, 1992.PubMedGoogle Scholar
  70. 66.
    Waring N-P, Ortenberg J, Galen WK, et al.: Priapism in Kawasaki disease. JAMA 261: 1730–1731, 1989.Google Scholar
  71. 67.
    Germain BF, Moroney JD, Guggino GS, et al.: Anterior uveitis in Kawasaki disease. J Pediatr 97: 780–781, 1980.PubMedGoogle Scholar
  72. 68.
    Rennebohm, MJ, Burke, MJ, Crowe, W, et al.: Anterior uveitis in Kawasaki disease, abstracted. Arthritis Rheum. 24 (Suppl).: 88, 1981.Google Scholar
  73. 69.
    Courtecuisse V, Decary F: Kawasaki disease: association with uveitis in seven patients. Pediatrics 69: 376–378, 1982.PubMedGoogle Scholar
  74. 70.
    Furusho K, Kamiya T, Nakano H, et al.: High-dose intravenous gamma-globulin for Kawasaki disease. Lancet 2: 1055–1058, 1984.PubMedGoogle Scholar
  75. 71.
    Newburger JW, Takahashi M, Burns JC, et al.: The treatment of Kawasaki syndrome with intravenous gamma globulin. N Engl J Med 315: 341–347, 1986.PubMedGoogle Scholar
  76. 72.
    Glode MP, Joffe LS, Wiggins J Jr., et al.: Effect of intravenous immune globulin on the coagulopathy of Kawasaki syndrome. J Pediatr 115: 469–473, 1989.PubMedGoogle Scholar
  77. 73.
    Barron KS, Murphy DJ Jr.: Kawasaki syndrome: still a fascinating enigma. Hosp Pract pp. 51–60, October 15, 1989.Google Scholar
  78. 74.
    Current therapy for acute Kawasaki syndrome. J Pediatr 118: 987–991, 1991.Google Scholar
  79. 75.
    Schackleford PG, Strauss AW: Kawasaki syndrome. N Engl J Med 324: 1664–1666, 1991.Google Scholar
  80. 76.
    Newburger JW, Takahashi M, Beiser AS, et al.: A single intravenous infusion of gamma globulin as compared with four infusions in the treatment of acute Kawasaki syndrome. N Engl J Med 324: 1633–1639, 1991.PubMedGoogle Scholar
  81. 77.
    Rowley AH, Duffy CE, Shulman ST: Prevention of giant coronary artery aneurysms in Kawasaki disease by intravenous gamma globulin therapy. J Pediatr 113: 290–294, 1988.PubMedGoogle Scholar
  82. 78.
    American Academy of Pediatrics: Committee on Infectious Diseases. Intravenous globulin use in children with Kawasaki disease. Pediatrics 82: 122, 1988.Google Scholar
  83. 79.
    Nakamura Y, Fujita Y, Nagai M, et al.: Cardiac sequelae of Kawasaki Disease in Japan: Statsitical Analysis. Pediatrics 88: 1144–1147, 1991.PubMedGoogle Scholar
  84. 80.
    Burks AW, Sampson HA, Buckley RH: Anaphylactic reactions after gamma globulin administration in patients with hypogammaglobulinemia. Detection of IgE antibodies to IgA. N EnglJ Med 314: 560–564, 1986.Google Scholar
  85. 81.
    Kato E, Shindo S, Eto Y, et al.: Administration of immune globulin associated with aseptic meningitis. JAMA 259: 3269–3272, 1988.Google Scholar
  86. a.Comentzo RL, Malachowski ME, Meissner HC, et al.: Immune hemolysis, disseminated intravascular coagulation, and serum sickness after large doses of immune globulin given intravenously for Kawasaki disease. J Pediatr 120: 926928, 1992.Google Scholar
  87. 82.
    White WB, Ryan RW, Staley DD, Ballow M: Passive transfer of antibodies to human T-cell lymphotropic virus type III in patients receiving high-dose intravenous immunoglobulin. JAMA 255: 2602–2603, 1986.Google Scholar
  88. 82a.
    a.Nakamura Y, Yanagawa H, Kawasaki T: Mortality among children with Kawasaki disease in Japan. N Eng J Med 326: 1246–1249, 1992.Google Scholar
  89. 83.
    Bierman FZ, Gersony WM: Kawasaki disease: clinical perspective. J Pediatr 111:789–792, 1987 (see also correspondence pp. 1116–1117).Google Scholar
  90. 84.
    Kato H, Koike S, Yokoyama T: Kawasaki disease: effect of treatment on coronary artery involvement Pediatrics 63: 175–179, 1979.Google Scholar
  91. 85.
    Koren G, Rose V, Lavi S, Rowe R: Probable efficacy of high dose salicylate in reducing coronary involvement in Kawasaki disease. JAMA 254: 767–769, 1985.Google Scholar
  92. 86.
    Koren G, Schaffer F, Silverman E, et al.: Determinants of low serum concentrations of salicylates in patients with Kawasaki disease. J Pediatr 112: 663–667, 1988.PubMedGoogle Scholar
  93. 87.
    Koren G, Macloed SM: Difficulty in achieving therapeutic serum concentrations of salicylate in Kawasaki disease. J Pediatr 105:991–995, 1984 (see also correspondence 106: 858–860, 1985 ).Google Scholar
  94. 88.
    Koren G, Lavi S, Rose V, Rowe R: Kawasaki disease: review of risk factors for coronary aneurysms. J Pediatr 108: 388–392, 1986.PubMedGoogle Scholar
  95. 89.
    Daniels SR, Specker B, Capannari TE, et al.: Correlates of coronary artery aneurysm formation in patients with Kawasaki disease. Am J Dis Child 141: 2057, 1987.Google Scholar
  96. 90.
    Nagashima M, Matsushima M, Matsuoka H, et al.: High-dose gammaglobulin therapy for Kawasaki disease. J Pediatr 110: 710–712, 1987.PubMedGoogle Scholar
  97. 91.
    Koren G, Silverman E, Sundel R, et al.: Decreased protein binding of salicylates in Kawasaki disease. J Pediatr 118: 456–459, 1991.PubMedGoogle Scholar
  98. 92.
    Melish ME: Kawasaki syndrome (mucocutaneous lymph node syndrome). Pediatr Rev 2: 107–114, 1980.Google Scholar
  99. 93.
    Burtt DM, Pollack P, Bianco JA: Intravenous streptokinase in an infant with Kawasaki’s disease complicated by acute myocardial infarcation. Pediatr Cardiol 6: 307–311, 1986.PubMedGoogle Scholar
  100. 94.
    Terai M, Ogaata M, Sugimoto K, et al.: Coronary arterial thrombi in Kawasaki disease. J Pediatr 106: 76–78, 1985.PubMedGoogle Scholar
  101. 95.
    Kato H, Koike S, Yamamoto M, et al.: Coronary aneurysms in infants and young children with acute mucocutaneous lymph node syndrome. J Pediatr 86: 892–898, 1975.PubMedGoogle Scholar
  102. 96.
    Glanz S, Bittner SJ, Berman MA, et al.: Regression of coronary artery aneurysms in infantile polyarteritis nodosa. N Engl J Med 294: 939–941, 1976.PubMedGoogle Scholar
  103. 97.
    Kato H: Natural history of Kawasaki disease. In Shiokawa Y (ed.) Vascular Lesions of Collagen Diseases and Related Conditions. University Park Press, Baltimore, 1977, pp. 282–295.Google Scholar
  104. 98.
    Nakano H, Ueda K, Saito A, Nojima K: Repeated quantitative angiograms in coronary arterial aneursym in Kawasaki disease. Am J Cardiol 56: 846–851, 1985.PubMedGoogle Scholar
  105. 99.
    Kato H, Inoue O, Akagi T: Kawasaki disease: cardiac problems and management. Pediatr Rev 9: 209–217, 1988.PubMedGoogle Scholar
  106. 100.
    Yoshikawa J, Yanagihara K, Owaki T, et al.: Cross-sectional echocardiographic diagnosis of coronary artery aneurysms in patients with the mucocutaneous lymph node syndrome. Circulation 59: 133–139, 1979.PubMedGoogle Scholar
  107. 101.
    Hiraishi S, Yashiro K, Kusano S: Noninvasive visualization of coronary arterial aneurysm in infants and young children with mucocutaneous lymph node syndrome with two-dimensional echocardiography. Am J Cardiol 43: 1225–1233, 1979.PubMedGoogle Scholar
  108. 102.
    Yoshida H, Funabashi T, Nakaya S, et al.: Mucocutaneous lymph node syndrome: a cross sectional echocardiographic diagnosis of coronary aneurysms. Am J Dis Child 133: 1244–1247, 1979.PubMedGoogle Scholar
  109. 103.
    Neches WH: Mucocutaneous lymph node syndrome: coronary artery disease and cross-sectional echocardiography. Am J Dis Child 133: 1233–1235, 1979.PubMedGoogle Scholar
  110. 104.
    Capannari TE, Daniels SR, Meyer RA, et al.: Sensitivity, specificity and predictive value of two-dimensional echocardiography in detecting coronary artery aneurysms in patients with Kawasaki disease. J Am Coll Cardiol 7: 355–360, 1986.PubMedGoogle Scholar
  111. 105.
    Tatara K, Kusakawa S: Long-term prognosis of giant coronary aneurysm in Kawasaki disease: an angiographic study. J Pediatr 111: 705–710, 1987.PubMedGoogle Scholar
  112. 106.
    Akiba T, Sato T, Yoshikawa M, et al.: Prognostic significance of the size of coronary artery aneurysms in Kawasaki disease. Acta Paediatr Jpn 31: 7–11, 1989.PubMedGoogle Scholar
  113. 107.
    Nakanishi T, Takao A, Nakazawa M, et al.: Mucocutaneous lymph node syndrome: clinical, hemodynamic and angiographic features of coronary obstructive disease. Am J Cardiol 55: 662–668, 1985.PubMedGoogle Scholar
  114. 108.
    Nakano H, Ueda K, Saito A, Nojima K: Repeated quantitative angiograms in coronary arterial aneurysm in Kawasaki disease. Am J Cardiol 56: 846–851, 1985.PubMedGoogle Scholar
  115. 109.
    Suzuki A, Kamiya T, Ono Y, et al.: Follow-up study of coronary artery lesions due to Kawasaki disease by serial selective coronary arteriography in 200 patients. Heart Vessels 3: 159–165, 1987.PubMedGoogle Scholar
  116. 110.
    Bisset GS III, Strife JL, McCloskey J: MR Imaging of coronary artery aneurysms in a child with Kawasaki disease. AJR 805–807, 1989.Google Scholar
  117. 111.
    Demer LL, et al.: Assessment of coronary artery disease severity by positron emission tomography: comparison with quantitative arteriography in 193 patients. Circulation 79: 825–835, 1989.PubMedGoogle Scholar
  118. 112.
    Kato H, Ichinose E, Kawasaki T: Myocardial infarcation in Kawasaki disease: clinical analyses in 195 cases. J Pediatr 108: 923–927, 1986.PubMedGoogle Scholar
  119. 113.
    Lipson MH, Ament ME, Fonkalsrud EW: Ruptured hepatic artery aneurysm and coronary artery aneurysms with myocardial infarction in a 14-year-old boy: new manifestations of mucocutaneous lymph node syndrome. J Pediatr 98: 933–936, 1981.PubMedGoogle Scholar
  120. 114.
    Hicks RV, Melish ME, Paik Y, et al.: Kawasaki syndrome (KS) 2 to 10 years later, abstracted. Arthritis Rheum 25 (Suppl): 125, 1981.Google Scholar
  121. 115.
    Spielmann RP, Nienaber CA, Hausdorf G, Montz R: Tomographie myocardial perfusion scintigraphy in children with Kawasaki disease. J Nucl Med 28: 1839–1843, 1987.PubMedGoogle Scholar
  122. 116.
    Nienaber CA, Spielmann RP, Hausdorf G: Dipyridamole-thallium-201 tomography documenting improved myocardial perfusion with therapy in Kawasaki disease. Am Heart J 116: 1575, 1988.PubMedGoogle Scholar
  123. 117.
    Paridon SM, Ross RD, Kuhns LR, Pinsky WW: Myocardial performance and perfusion during exercise in patients with coronary artery disease caused by Kawasaki disease. J Pediatr 116: 52–56, 1990.PubMedGoogle Scholar
  124. 118.
    Sandiford FM, Vargo TA, Shih JY, et al.: Successful triple coronary artery bypass in a child with multiple coronary aneurysms due to Kawasaki’s disease. J Thorac Cardiovasc Surg 79: 283–287, 1980.PubMedGoogle Scholar
  125. 119.
    Suzuki A, Kamiya T, Ono Y, et al.: Myocardial ischemia in Kawasaki disease: follow-up study by cardiac catheterization and coronary angiography. Pediatr Cardiol 9: 1–5, 1988.PubMedGoogle Scholar
  126. 120.
    Suzuki A, Kamiya T, Ono Y, et al.: Aortocoronary bypass surgery for coronary arterial lesions resulting from Kawasaki disease. J Pediatr 116: 567–573, 1990.PubMedGoogle Scholar
  127. 121.
    FitzGerald GA: Dipyridamole. N Engl J Med 316:1247–1256, 1987 (see also correspondence pp. 1734–1736).Google Scholar
  128. 122.
    Nakano H, Ueda K, Saito A, Tsuchitani Y: Doppler detection of tricuspid regurgitation following Kawasaki’s disease. Pediatr Radiol 16: 123–125, 1990.Google Scholar
  129. 123.
    Nakano H, Nojima K, Saito A, Ueda K: High incidence of aortic regurgitation following Kawasaki disease. J Pediatr 59–63, 1985.Google Scholar
  130. 124.
    Kurisu Y, Azumi T, Sugahara T, et al.: Variation in coronary arterial dimension (distensible abnormality) after disappearing aneurysm in Kawasaki disease. Am Heart J 114: 532–538, 1987.PubMedGoogle Scholar
  131. 125.
    Lightfoot RW Jr., Michel BA, Bloch DA, et al.: The American College of Rheumatology 1990 Criteria For The Classification of Polyarteritis Nodosa. Arthritis Rheum 33: 1088–1093, 1990.PubMedGoogle Scholar
  132. 126.
    Blau EB, Morris RF, Yunis EJ: Polyarteritis nodosa in older children. Pediatrics 60: 227–234, 1977.PubMedGoogle Scholar
  133. 127.
    Reimold EW, Weinberg AG, Fink CW, et al.: Polyarteritis in children. Am J Dis Child 130: 534–541, 1976.PubMedGoogle Scholar
  134. 128.
    Magilavy DB, Petty RE, Cassidy JT, et al.: A syndrome of childhood polyarteritis. J Pediatr 91: 25–30, 1977.PubMedGoogle Scholar
  135. 129.
    Ettlinger RE, Nelson AM, Burke EC, et al.: Polyarteritis nodosa in childhood, a clinical pathologic study. Arthritis Rheum 22: 820–825, 1979.PubMedGoogle Scholar
  136. a.Ozen S, Besbas N, Saatci U, Bakkaloglu A: Diagnostic criteria for polyarteritis nodosa in children. J Pediatr 120: 206–209, 1992.Google Scholar
  137. 130.
    Woodward AH, Andreini PH: Periosteal new bone formation in polyarteritis nodosa. Arthritis Rheum 17: 1017–1025, 1974.PubMedGoogle Scholar
  138. 131.
    SergentJS, Lochshin MD, Christian CL, et al.: Vasculitis with hepatitis B antigenemia. Medicine 55: 1–18, 1976.PubMedGoogle Scholar
  139. 132.
    Duffy J, Lidsky MD, Sharp JT, et al.: Polyarthritis, polyarteritis and hepatitis B. Medicine 55: 19–37, 1976.PubMedGoogle Scholar
  140. 133.
    Reznik VM, Mendoza SA, Self TW, et al.: Hepatitis B-associated vasculitis in an infant. J Pediatr 98: 252–254, 1981.PubMedGoogle Scholar
  141. 134.
    McMahon BJ, Bender TR, Templin DW, et al.: Vasculitis in Eskimos living in an area hyperendemic for hepatitis B. JAMA 244: 2180–2182, 1980.Google Scholar
  142. 135.
    Ingelfinger, JR, McCluskey RT, Schneeberger EE: Necrotizing arteritis in acute poststreptococcal glomerulonephritis. J Pediatr 91: 228–232, 1977.PubMedGoogle Scholar
  143. 136.
    Bamji A, Salisbury, R: Cytomegalovirus and vasculitis. Br Med J 1: 623–624, 1978.PubMedGoogle Scholar
  144. 137.
    Hoffman GS, Franck WA: Infectious mononucleosis, autoimmunity and vasculitis. A case report. JAMA 241: 2735–2736, 1979.Google Scholar
  145. 138.
    Finkel TH, Gelfand EW, Harbeck R, et al.: Chronic parvovirus infection presenting as juvenile polyarteritis nodosum. Arthritis Rheum 33: 5132, 1990.Google Scholar
  146. 139.
    SergentJS, Christian CL: Necrotizing vasculitis after acute serous otitis media. Ann Intern Med 81: 195–199, 1974.Google Scholar
  147. 140.
    Soter NA, Mihm MC, Colten HR: Cutaneous necrotizing venulitis in patients with cystic fibrosis. J Pediatr 95: 197–201, 1979.PubMedGoogle Scholar
  148. 141.
    Berdischewsky M, Pollack M, Young LS, et al.: Circulating immune complexes in cystic fibrosis. J Pediatr Res 14: 830–833, 1980.Google Scholar
  149. 141a.
    Case Records of the Massachusetts General Hospital. Case 18–1992. N Engl J Med 326: 1204–1212, 1992.Google Scholar
  150. 141b.
    Jennette JC, Falk RJ. Disease associations and pathogenic role of antineutrophil cytoplasmic autoantibodies in vasculitis. Current Opinion in Rheumatology 4: 9–15, 1992.PubMedGoogle Scholar
  151. 142.
    Wees SJ, Oh SJ: Sural nerve biopsies in systemic vasculitis, abstracted. Arthritis Rheum 24 (Suppl.): 88, 1981.Google Scholar
  152. 143.
    Albert DA, Rimon D, Silverstein MD, et al.: The diagnosis of polyarteritis nodosa. Arthritis Rheum 31: 1117–1134, 1988.PubMedGoogle Scholar
  153. 144.
    Bron KM, Strott CA, Shapiro AP: The diagnostic value of angiographic observations in polyarteritis nodosa. Arch Intern Med 116: 450–454, 1965.PubMedGoogle Scholar
  154. 145.
    Hilal SK, Solomon GE, Gold A, et al.: Primary cerebral arterial occlusive disease in children. Radiology 99: 71–86, 1971.PubMedGoogle Scholar
  155. 146.
    Mason RA, Arbeit LA, Giron F: Renal dysfunction after arteriography. JAMA 253:1001–1004, 1985 (see also correspondence 254: 233–234, 1985 ).Google Scholar
  156. 147.
    Dahlberg PJ, Lockhart JM, Overholt EL: Diagnostic studies for systemic necrotizing vasculitis: sensitivity, specificity, and predictive value in patients with multisystem disease. Arch Intern Med 149: 161–165, 1989.PubMedGoogle Scholar
  157. 148.
    Fauci AS, Katz P, Haynes BF, et al.: Cyclophosphamide therapy of severe systemic necrotizing vasculitis. N Engl J Med 301: 235–238, 1979.PubMedGoogle Scholar
  158. 149.
    Guillevin L, Fain O, Lhote F, et al: Lack of superiority of steroids plus plasma exchange to steroids alone in the treatment of polyarteritis nodosa and ChurgStrauss syndrome. A prospective, randomized trial in 78 patients. Arthritis Rheum 35: 208–215, 1992.PubMedGoogle Scholar
  159. 150.
    Cunningham RJ III, Gilfoil M, Cavallo T, et al.: Rapidly progressive glomerulonephritis in children: a report of thirteen cases and a review of the literature. Pediatr Res 14: 128–132, 1980.PubMedGoogle Scholar
  160. 151.
    McCune WJ, Friedman AW. Immunosuppressive drug therapy for rheumatic disease. Current Opinion in Rheumatology 4: 314–321, 1992.PubMedGoogle Scholar
  161. 152.
    Scott DGI, Bacon PA: Intravenous cyclophosphamide plus methylprednisolone in treatment of systemic rheumatoid vasculitis. Am J Med 76: 377–384, 1984.PubMedGoogle Scholar
  162. 153.
    Fort JG, Abruzzo JL: Reversal of progressive necrotizing vasculitis with intravenous pulse cyclophosphamide and methylprednisolone. Arthritis Rheum 31: 1194–1198, 1988.PubMedGoogle Scholar
  163. 154.
    Fauci AS, Doppman JL, Wolff SM: Cyclophosphamide-induced remissions in advanced polyarteritis nodosa. Am J Med 64: 890–894, 1978.PubMedGoogle Scholar
  164. 155.
    Chumbley LC, Harrison EG, Jr, DeRemee RA: Allergic granulomatosis and angiitis (Churg-Strauss syndrome). Report and analysis of 30 cases. Mayo Clin Proc 52: 477–484, 1977.PubMedGoogle Scholar
  165. 156.
    Farooki ZQ, Brough AJ, Green EW: Necrotizing arteritis. Am J Dis Child 128: 837–840, 1974.PubMedGoogle Scholar
  166. 157.
    Lanham JG, Elkon KB, Pusey CD, Hughes GR: Systemic vasculitis with asthma and eosinophilia: a clinical approach to the Churg-Strauss syndrome. Medicine 63: 65–81, 1984.PubMedGoogle Scholar
  167. 158.
    Masi AT, Hunder GG, Lie JT, et al.: The American College of Rheumatology 1990 Criteria For The Classification of Churg-Strauss Syndrome (Allergic Granulomatosis and Angiitis). Arthritis Rheum 33: 1094–1100, 1990.PubMedGoogle Scholar
  168. 159.
    McCombs RP: Diseases due to immunologic reactions in the lung. N Engl J Med 286: 1186–1194, 1972.PubMedGoogle Scholar
  169. 160.
    Chauhan A, Scott DGI, Neuberger J, et al.: Churg-Strauss vasculitis and ascaris infection. Ann Rheum Dis 49: 320–322, 1990.PubMedGoogle Scholar
  170. 161.
    Frayha RA: Churg-Strauss syndrome in a child. J Rheumatol 9:807–809, 1982 (Letters).Google Scholar
  171. 162.
    Fischer TJ, Daughtery C, Gushurst C, et al.: Systemic vasculitis associated with eosinophilia and marked degranulation of tissue eosinophils. Pediatrics 82: 6975, 1988.Google Scholar
  172. 163.
    Finan MC, Winkelmann RK: The cutaneous extravascular necrotizing granuloma (Churg-Strauss granuloma) and systemic disease: a review of 27 cases. Medicine 62: 142–158, 1983.PubMedGoogle Scholar
  173. 164.
    Case records of the Massachusetts General Hospital: Case 46–1980. N Engl J Med 303: 1218–1225, 1980.Google Scholar
  174. 165.
    Case records of the Massachusetts General Hospital. Case 18–1987. N Engl J Med 316: 1139–1147, 1987.Google Scholar
  175. 166.
    Vincent FM: Granulomatous angiitis. N Engl J Med 296: 452. 1977.PubMedGoogle Scholar
  176. 167.
    Sandhu R, Alexander WS, Hornabrook RW, et al.: Granulomatous angiitis of the central nervous system. Arch Neurol 36: 433–435, 1979.PubMedGoogle Scholar
  177. 168.
    Allen GL, Nelson AM, Gomez MR: Isolated central nervous system (CNS) vasculitis in childhood-a report of five cases with long term followup, Mayo Clinic. Personal communication.Google Scholar
  178. 169.
    Calabrese LH, Furlan AJ, Gragg LA, Ropos TJ. Primary angiitis of the central nervous system: Diagnostic criteria and clinical approach. Cleve Clin J Med 59: 293–306, 1992.PubMedGoogle Scholar
  179. 170.
    Lie JT: Angiitis of the central nervous system. Curr Opin Rheumatol 3: 36–45, 1991.PubMedGoogle Scholar
  180. 171.
    Crane R, Kerr LD, Spiera H: Clinical analysis of isolated angiitis of the central nervous system. A report of 11 cases. Arch Intern Med 151: 2290–2294, 1991.PubMedGoogle Scholar
  181. 172.
    Case records of the Massachusetts General Hospital. Case 16–1986. N Engl J Med 315: 1143–1154, 1986.Google Scholar
  182. 173.
    Leavitt RY, Fauci AS: Polyangiitis overlap syndrome: classification and prospective clinical experience. Am J Med 81: 79–85, 1986.PubMedGoogle Scholar
  183. 174.
    Case Records of the Massachusetts General Hospital. Case 8–1989. N Engl J Med 320: 514–524, 1989.Google Scholar
  184. 175.
    Sigal LH: The neurologic presentation of vasculitic and rheumatologic syndromes: a review. Medicine 66: 157–180, 1987.PubMedGoogle Scholar
  185. 176.
    Loeffel S, Chang CH, Heyn R, et al.: Necrotizing lymphoid vasculitis in X-linked lymphoproliferative syndrome. Arch Pathol Lab Med 109: 546–550, 1985.PubMedGoogle Scholar
  186. 177.
    Stein RL, Martino CR, Weinert DM, et al.: Cerebral angiography as a guide for therapy in isolated central nervous system vasculitis. JAMA 257: 2193–2196, 1987.Google Scholar
  187. 178.
    Rush PJ, Inman R, Bernstein M, et al.: Isolated vasculitis of the central nervous system in a patient with celiac disease. Am J Med 81: 1092–1094, 1986.PubMedGoogle Scholar
  188. 179.
    Pasternak JF, DeVivo DC, Prensky AL: Steroid-responsive encephalomyelitis in childhood. Neurology 30: 481–486, 1980.PubMedGoogle Scholar
  189. 180.
    Nakao K, Ikeda M, Shinichi K, et al.: Takayasu’s arteritis: clinical report of eighty-four cases and immunological studies of seven cases. Circulation 35: 1141–1155, 1967.PubMedGoogle Scholar
  190. 181.
    Bonventre MV: Takayasu’s disease revisited. NY State J Med 74: 1960–1967, 1974.Google Scholar
  191. 182.
    Lupi-Herrera E, Sanchez-Torres G, Marcushamer J, et al.: Takayasu’s arteritis. Clinical study of 107 cases. Am Heart J 93: 94–103, 1977.PubMedGoogle Scholar
  192. 183.
    Haas A, Stiehm ER: Takayasu’s arteritis presenting as pulmonary hypertension. Am J Dis Child 140: 372–374, 1986.PubMedGoogle Scholar
  193. 184.
    Lande A, Berkmen YM, McAllister HA Jr (eds.): Aortitis: Clinical, Pathologic and Radiographic Aspects. Raven Press, New York, 278 pp., 1986, illustrated.Google Scholar
  194. 185.
    Arend WP, Michel BA, Bloch DA, et al.: The American College of Rheumatology 1990 Criteria For The Classification of Takayasu Arteritis. Arthritis Rheum 33: 1129–1134, 1990.PubMedGoogle Scholar
  195. 186.
    Hall S, Barr W, Lie JT, et al.: Takayasu arteritis: a study of 32 North American patients. Medicine 64: 89–99, 1985.PubMedGoogle Scholar
  196. 187.
    Shelhamer JH, Volkman DJ, Parrillo JE, et al.: Takayasu’s Arteritis and its therapy. Ann Intern Med 103: 121–126, 1985.PubMedGoogle Scholar
  197. 188.
    Wu YJ J, Martin B, Ong K, et al.: Takayasu’s arteritis as a cause of fever of unknown origin. Am J Med 87: 476, 1989.PubMedGoogle Scholar
  198. 189.
    Tanaka N, Tanaka H, Toyama Y, et al.: Paroxysmal hypertension in aortitis syndrome. Am Heart J 90: 369–375, 1975.PubMedGoogle Scholar
  199. 190.
    Lande A, Rossi P: The value of total aortography in the diagnosis of Takayasu’s arteritis. Radiology 114: 287–297, 1975.PubMedGoogle Scholar
  200. 191.
    Lande A, Bard R, Rossi P, et al.: Takayasu’s arteritis. NY State J Med 76: 1474–1482, 1976.Google Scholar
  201. 192.
    Lacombe P, Frija G, Boucher D, et al.: Maladie de Takayasu: Interet de l’angiographie numerique intraveineuse: 44 observations. Presse Med 15:11791182, 1986. (Takayasu’s Arteritis: Usefulness of Digital Intravenous Angiography: 44 Cases.)Google Scholar
  202. 192a.
    a.Tanigawa K, Eguchi K, Kitamura Y, et al.: Magnetic resonance imaging detection of aortic and pulmonary artery wall thickening in the acute stage of Takayasu arteritis. Improvement of clinical and radiologie findings after steroid therapy. Arthritis Rheum 35: 476–480, 1992.PubMedGoogle Scholar
  203. 193.
    Hellmann DB, Hardy K, Lindenfeld S, Ring E: Takayasu’s arteritis associated with crescentic glomerulonephritis. Arthritis Rheum 451–454, 1987.Google Scholar
  204. 194.
    Cajigas JC, Amigo MC, Pineda C, et al.: Association between Takayasu’s arteritis and cutaneous polyarteritis nodosa. Am J Med 82: 382–384, 1987.PubMedGoogle Scholar
  205. 195.
    Perniciaro C, Winkelmann RK: Cutaneous extravascular necrotizing granuloma in a patient with Takayasu’s aortitis. Arch Dermatol 122: 201, 1986.PubMedGoogle Scholar
  206. 196.
    Wiggelinkhuizen J, Cremin BJ: Takayusu arteritis and renovascular hypertension in childhood. Pediatrics 62: 209–217, 1978.PubMedGoogle Scholar
  207. 197.
    Pantell RH, Goodman BW Jr: Takayasu’s arteritis: The relationship with tuberculosis. Pediatrics 67: 84–88, 1981.PubMedGoogle Scholar
  208. 198.
    Abe K, Miyazaki S, Kusaka T, et al.: Elevated plasma renin activity in aortitis syndrome. Jap Heart J 17: 1–11, 1976.PubMedGoogle Scholar
  209. 199.
    Rotenstein D, Gibbas DL, Majmudar B, et al.: Familial granulomatous arteritis associated with polyarthritis of juvenile onset. N Engl J Med 306: 86–90, 1982.PubMedGoogle Scholar
  210. 200.
    Hoffman GS, Kerr GS, Leavitt RY, et al.: Wegener granulomatosis: An analysis of 158 patients. Ann Int Med 116: 488–498, 1992.PubMedGoogle Scholar
  211. 201.
    Hall SL, Miller LC, Duggan E, et al.: Wegener’s granulomatosis in pediatric patients. J Pediatr 106: 739–744, 1985.PubMedGoogle Scholar
  212. 202.
    Leavitt RY, Fauci AS, Bloch DA, et al.: The American College of Rheumatology 1990 Criteria for the Classification of Wegener’s Granulomatosis. Arthritis Rheum 33: 1101–1107, 1990.PubMedGoogle Scholar
  213. 203.
    Case Records of the Massachusetts General Hospital: Case 12–1986. N Engl J Med 31: 834–844, 1986.Google Scholar
  214. 204.
    Myers JL, Katzenstein A-L A: Wegener’s granulomatosis presenting with massive pulmonary hemorrhage and capillaritis. Am J Surg Pathol 11: 895–898, 1987.PubMedGoogle Scholar
  215. 205.
    Appel GB, Gee B, Kashgarian M, et al.: Wegener’s granulomatosis-clinical-pathologic correlations and long-term course. Am J Kidney Dis 1: 27–37, 1981.PubMedGoogle Scholar
  216. a.Charles SJ, Meyer PAR, Watson PG: Diagnosis and management of systemic Wegener’s granulomatosis presenting with anterior ocular inflammatory dis-Google Scholar
  217. ease. Br J Opthalmol 75: 201–207, 1991.Google Scholar
  218. 205b.
    Sacks RD, Stock EL, Crawford SE, et al.: Scleritis and Wegener’s granulomatosis in children. Am J Opthalmol 111: 430–433, 1991.Google Scholar
  219. 206.
    Yoshikawa Y, Watanabe T: Pulmonary lesions in Wegener’s granulomatosis: A clinicopathologic study of 22 autopsy cases. Hum Pathol 17: 401–410, 1986.PubMedGoogle Scholar
  220. 207.
    Leavitt RY, Fauci AS: Pulmonary vasculitis. Am Rev Respir Dis 134: 149–166, 1986.PubMedGoogle Scholar
  221. 208.
    Mark EJ, Matsubara O, Tan-Liu NS, Fienberg R: The pulmonary biopsy in the early diagnosis of Wegener’s (pathergic) granulomatosis: a study based on 35 open lung biopsies. Human Pathol 19: 1065–1071, 1988.Google Scholar
  222. 208a.
    a.Lowance DC, Vosatka K, Whelchel J, et al.: Recurrent Wegener’s granulomatosis. Am J Med 92: 573–575, 1992.PubMedGoogle Scholar
  223. 209.
    Norris MJ, Tomecki KJ, Bergfeld WF, Wilke WS: Cutaneous Wegener’s granulomatosis: report of a case and review of the literature. Clev Clin J Med 55: 18 1184, 1988.Google Scholar
  224. 210.
    Case Records of the Massachusetts General Hospital: Case 17–1986. N Engl J Med 314: 1170–1184, 1986.Google Scholar
  225. 211.
    Cohen Tervaert JW, van der Woude FJ, Fauci AS, et al.: Association between active Wegener’s granulomatosis and anticytoplasmic antibodies. Arch Intern Med 149:2461–2465, 1989 (see also pp. 2401–2402).Google Scholar
  226. 212.
    Maclsaac AI, Davies DJ, Moran JE, et al.: Correspondence: antineutrophilic cytoplasmic antibodies in systemic vasculitis. Mayo Clin Proc 65: 124–125, 1990.Google Scholar
  227. 213.
    Jennette JC, Wilkman AS, Falk RJ: Anti-neutrophil cytoplasmic autoantibodyassociated glomerulonephritis and vasculitis. A J Pathol 135: 921–930, 1989.Google Scholar
  228. 214.
    Falk FJ, Hogan S, Caey TS, et al.: Clinical course of anti-neutrophil cytoplasmic autoantibody-associated glomerulonephritis and systemic vasculitis. Ann Intern Med 113: 656–663, 1990.PubMedGoogle Scholar
  229. 215.
    Moorthy AV, Chesney RW, Segar WE, et al.: Wegener’s granulomatosis in childhood: prolonged survival following cytotoxic therapy. J Pediatr 91: 616618, 1977.Google Scholar
  230. 216.
    Orlowski JP, Clough JD, and Dyment PG: Wegener’s granulomatosis in the pediatric age group. Pediatrics 61: 83–90, 1978.PubMedGoogle Scholar
  231. 217.
    Baliga R, Chang CH, Bidani AK, et al.: A case of generalized Wegener’s granulomatosis in childhood: successful therapy with cyclophosphamide. Pediatrics 61: 286–290, 1978.PubMedGoogle Scholar
  232. 218.
    Hoffman GS, Leavitt RY, Fleisher TA, et al.: Treatment of Wegener’s granulomatosis with intermittent high-dose intravenous cyclophosphamide. Am J Med 89:403–410, 1990 (see also Editorial pp. 399–402).Google Scholar
  233. 219.
    Harrison HL, Linshaw MA, Lindsley CB, et al.: Bolus corticosteroids and cyclophosphamide for initial treatment of Wegener’s granulomatosis. JAMA 244: 1599–1600, 1980.Google Scholar
  234. 220.
    Kroneman OC, Pevzner M: Failure of cyclophosphamide to prevent cerebritis in Wegener’s granulomatosis. Am J Med 80: 526–527, 1986.PubMedGoogle Scholar
  235. 221.
    Pinching AJ, Lockwood CM, Pussell BA, et al.: Wegener’s granulomatosis: observations on 18 patients with severe renal disease. Q J Med 208: 435–460, 1983.Google Scholar
  236. 222.
    Rottem M, Fauci AS, Hallahan CW, et al.: A long term study of Wegener granulomatosis in 23 children and adolescents: Clinical presentation and outcome. J Pediatr In Press, 1993.Google Scholar
  237. 223.
    DeRemee RA: The treatment of Wegener’s granulomatosis with trimethoprim/ sulfamethoxazole: illusion or vision? Arthritis Rheum 31:1068–1072, 1988 (see also 32: 1051–1052, 1989 ).Google Scholar
  238. 224.
    Israel HL: Sulfamethoxazole-trimethoprim therapy for Wegener’s granulomatosis. Arch Intern Med 148:2293–2295, 1988 (see also correspondence 149: 1469, 1471 ).Google Scholar
  239. 225.
    Valeriano-Marcet J, Spiera H: Treatment of Wegener’s granulomatosis with sulfamethoxazole-trimethoprim. Arch Intern Med 151: 1649–1652, 1991.PubMedGoogle Scholar
  240. 226.
    Ambrus JL Jr, Fauci AS: Diffuse histiocyctic lymphoma in a patient treated with cyclophosphamide for Wagener’s granulomatosis. Am J Med 76: 745–747, 1984.PubMedGoogle Scholar
  241. 227.
    Case records of the Massachusetts General Hospital, Case no. 43–1981. N Engl J Med 305: 999–1008, 1981.Google Scholar
  242. 228.
    Lugmani RA, Adu D, Michael J: Limited Wegener’s granulomatosis: mild disease or distinct entity? Arthritis Rheum 33: S132, 1990.Google Scholar
  243. 229.
    Case Records of the Massachusetts General Hospital: Case 26–1985. N Engl J Med 312: 1695–1703, 1985.Google Scholar
  244. 230.
    Liebow AA, Carrington CRB, Friedman PJ: Lymphomatoid granulomatosis. Hum Pathol 3: 457–558, 1972.PubMedGoogle Scholar
  245. 231.
    Gracey DR, DeRemee RA, Colby TV, et al.: Benign lymphocytic angiitis and granulomatosis: experience with three cases. Mayo Clin Proc 63: 323–331, 1988.PubMedGoogle Scholar
  246. 232.
    Pisani RJ, DeRemee RA: Clinical implications of the histopathologic diagnosis of pulmonary lymphomatoid granulomatosis. Mayo Clin Proc 65: 151–163, 1990.PubMedGoogle Scholar
  247. 233.
    Katzenstein AL, Carrington CB, Liebow AA: Lymphomatoid granulomatosis; A clinicopathologic study of 152 cases. Cancer 43: 360–373, 1979.PubMedGoogle Scholar
  248. 234.
    Lipford EH Jr, Margolick JB, Longo DL, et al.: Angiocentric immunoproliferative lesions: a clinicopathologic spectrum of post-thymic T-cell proliferations. Blood 72: 1674–1681, 1988.PubMedGoogle Scholar
  249. 235.
    Case Records of the Massachusetts General Hospital: Case 40–1987. N Engl J Med 317: 879–890, 1987.Google Scholar
  250. 236.
    Foley JF, Linder J, Koh J, et al.: Cutaneous necrotizing granulomatous vasculitis with evolution to T cell lymphoma. Am J Med 82: 839–844, 1987.PubMedGoogle Scholar
  251. 237.
    Myers JL: Editorial: lymphomatoid granulomatosis: past, present,chrw(133) future? Mayo Clin Proc 65: 274–278, 1990.PubMedGoogle Scholar
  252. 238.
    Fillipovich AH, Krivit W, Kersey JH, Burke BA: Fatal arteritis as a complication of Wiskott-Aldrich syndrome. J Pediatr 95: 742–744, 1979.Google Scholar
  253. 239.
    Ilowite NT, Fligner CL, Ochs HD, et al.: Pulmonary angiitis with atypical lymphoreticular infiltrates in Wiskott-Aldrich syndrome: possible relationship of lymphomatoid granulomatosis and EBV infection. Clin Immunol Immunopathol 41: 479–484, 1986.PubMedGoogle Scholar
  254. 240.
    Letendre L: Treatment of lymphomatoid granulomatosis: old and new perspectives. Semin Respir Med 10: 178–181, 1989.Google Scholar
  255. 241.
    Fauci AS, Johnson RE, Wolff SM: Radiation therapy of midline granuloma. Ann Intern Med 84: 140–147, 1976.PubMedGoogle Scholar
  256. 242.
    Jones SK, Lane AT, Golitz LE, Weston WL: Cutaneous periarteritis nodosa in a child. Am J Dis Child 139: 920–922, 1985.PubMedGoogle Scholar
  257. 243.
    Moreland LW, Ball GV: Cutaneous polyarteritis nodosa. Am J Med 88: 426–430, 1990.PubMedGoogle Scholar
  258. 244.
    Calabrese LH, Michel BA, Bloch DA, et al.: The American College of Rheumatology 1990 Criteria For The Classification of Hypersensitivity Vasculitis. Arthritis Rheum 33: 1108–1113, 1990.PubMedGoogle Scholar
  259. 245.
    Meredith GS, Mitnick HJ, Burstin HE, Zimmerman SS: Polyarteritis nodosa presenting with migratory soft tissue swelling. NYS J Med 87: 402–403, 1987.Google Scholar
  260. 246.
    Ferreiro JE, Saldana MJ, Azevedo SJ: Polyarteritis manifesting as calf myositis and fever. Am J Med 80: 312–315, 1986.PubMedGoogle Scholar
  261. 247.
    Mathieson PW, Cobbold SP, Hale G, et al.: Monoclonal-antibody therapy in systemic vasculitis. N Engl J Med 323: 250–254, 1990.PubMedGoogle Scholar
  262. 248.
    Levo Y: Nature of cryoglobulinemia. Lancet 1: 285–287, 1980.PubMedGoogle Scholar
  263. 249.
    Meltzer M, Franklin EC: Cryoglobulinemia-a study of 29 patients. Am J Med 40: 828–836, 1966.PubMedGoogle Scholar
  264. 250.
    Gorevic PD, Kassab HJ, Levo Y, et al.: Mixed cryoglobulinemia: Clinical aspects and long-term follow-up of 40 patients. Am J Med 69: 287–308, 1980.PubMedGoogle Scholar
  265. 251.
    Reza MJ, Roth BE, Pops MA, et al.: Intestinal vasculitis in essential, mixed cryoglobulinemia. Ann Intern Med 81: 632–634, 1974.PubMedGoogle Scholar
  266. 252.
    Gamble CN, Ruggles SW: The immunopathogenesis of glomerulonephritis associated with mixed cryoglobulinemia. N Engl J Med 299: 81–84, 1978.PubMedGoogle Scholar
  267. 253.
    Waterman JR, Winkelstein JA, Berzofsky RN, et al.: Early complement component depletion and mixed cryoglobulinemia in a “healthy” family. Arthritis Rheum 22: 1006–1012, 1979.PubMedGoogle Scholar
  268. 254.
    Farivar M, Wands JR, Benson GD, et al.: Cryoprotein complexes and peripheral neuropathy in a patient with chronic active hepatitis. Gastroenterology 71: 490–492, 1976.PubMedGoogle Scholar
  269. 255.
    Cosgriff TM, Arnold WJ: Digital vasospasm and infarction associated with hepatitis B antigenemia. JAMA 235: 1362–1363, 1976.Google Scholar
  270. a. Knox TA, Hillyer CD, Kaplan MM, Berkman EM. Mixed cryoglobulinemia responsive to interferon-a. Am J Med 91:554–555, 1991. (See also 93:115–116, 1992.)Google Scholar
  271. 256.
    McDuffie FC, Sams WM Jr, Maldonado JE, et al.: Hypocomplementemia with cutaneous vasculitis and arthritis. Mayo Clin Proc 48: 340–347, 1973.PubMedGoogle Scholar
  272. 257.
    Feig PU, Soter NA, Yager HM, et al.: Vasculitis with urticaria, hypocomplementemia, and multiple system involvement. JAMA 236: 2065–2068, 1976.Google Scholar
  273. 258.
    Ludivico CL, Myers AR, Maurer K: Hypocomplementemic urticarial vasculitis with glomerulonephritis and pseudotumor cerebri. Arthritis Rheum 22: 1024–1028, 1979.PubMedGoogle Scholar
  274. 259.
    Lieberman J, Gephardt G, Calabrese LH: Urticaria, nephritis, and pseudotumor cerebri. Cleve Clin J Med 57: 197–201, 1990.PubMedGoogle Scholar
  275. 260.
    Miller JJ, Fries JF: Simultaneous vasculitis in a mother and newborn infant. J Pediatr 87: 443–445, 1975.PubMedGoogle Scholar
  276. 261.
    Elkon KB, Hughes GRV, Catovsky D, et al.: Hairy-cell leukemia with polyarteritis nodosa. Lancet 2: 280–282, 1979.PubMedGoogle Scholar
  277. 262.
    Longley S, Caldwell JR, Panush RS: Paraneoplastic vasculitis: unique syndrome of cutaneous angiitis and arthritis associated with myeloproliferative disorders. Am J Med 8Q: 1027–1030, 1986.Google Scholar
  278. 263.
    Vasily DB, Tyler WB: Propylthiouracil-induced cutaneous vasculitis. JAMA 243: 458–461, 1980.Google Scholar
  279. 264.
    Lanzkowsky P, Jayabose SJ, Shende R, et al.: Vasculitis as a complication of high-dose methotrexate in the treatment of acute leukemia. Am J Dis Child 130: 675, 1976.PubMedGoogle Scholar
  280. 265.
    Dewar HA, Peaston MJT. Three cases resembling polyarteritis nodosa arising during treatment with guanethidine. Br Med J 12: 609, 1964.Google Scholar
  281. 266.
    Cassorla FO, Finegold DN, Parks JS, et al.: Vasculitis, pulmonary cavitation, and anemia during antithyroid drug therapy. Am J Dis Child 137: 118–122, 1983.PubMedGoogle Scholar
  282. 267.
    Gaffey CM, Chun B, Harvey JC, Manz HJ: Phenytoin-induced systemic granulomatous vasculitis. Arch Pathol Lab Med 110: 131–135, 1986.PubMedGoogle Scholar
  283. 267a.
    a.Reid TJ III, Lombardo FA, Redmond J III, et al.: Digital vasculitis associated with interferon therapy. AmJ Med 92: 702–703, 1992.Google Scholar
  284. 268.
    Golbranson FL, Lurie L, Vance RM, et al.: Multiple extremity amputations in hypotensive patients treated with dopamine. JAMA 243: 1145–1146, 1980.Google Scholar
  285. 269.
    Forman HP, Levin S, Stewart B: Cerebral vasculitis and hemorrhage in an adolescent taking diet pills containing phenylpropanolamine: case report and review of literature. Pediatrics 83: 737–741, 1989.PubMedGoogle Scholar
  286. 270.
    Citron BP, Halpern M, McCarron M, et al.: Necrotizing angiitis associated with drug abuse. N Engl J Med 283: 1003–1011, 1970.PubMedGoogle Scholar
  287. 271.
    Halper M, Citron BP: Necrotizing angiitis associated with drug abuse. Am J Roentgenol Radium Ther Nucl Med 3: 663–671, 1971.Google Scholar
  288. 272.
    Wacker FJ, Tytojat GN, Vreeken J: Necrotizing vasculitis and ulcerative colitis. Br Med J 4: 83–84, 1974.Google Scholar
  289. 273.
    Forrest JA, Shearman DJ: Pulmonary vasculitis and ulcerative colitis. Am J Dig Dis 20: 482–486, 1975.PubMedGoogle Scholar
  290. 274.
    Edwards KR: Hemorrhagic complications of cerebral arteritis. Arch Neurol 34: 549–552, 1977.PubMedGoogle Scholar
  291. 275.
    Ho EC, Moss AJ: The syndrome of “mesenteric arteritis” following surgical repair of aortic coarctation. Pediatrics 49: 40–45, 1972.PubMedGoogle Scholar
  292. 276.
    Diaz-Perez JL, Winkelmann RK: Cutaneous periarteritis nodosa. Arch Dermatol 110: 407–414, 1974.PubMedGoogle Scholar
  293. 277.
    Cherubin CE: So-called cutaneous polyarteritis nodosa. NY State J Med 66: 1673–1678, 1966.Google Scholar
  294. 278.
    Milstone LM, Braverman IM, Lucky P, Fleckman P: Classification and therapy of atrophie blanche. Arch Dermatol 119: 963–969, 1983.PubMedGoogle Scholar
  295. 279.
    Baethge BA, Sanusi ID, Landreneau MD, et al.: Livedo reticularis and peripheral gangrene associated with primary hyperoxaluria. Arthritis Rheum 31: 1199–1203, 1988.PubMedGoogle Scholar
  296. 280.
    Heine KG: Idiopathic atrophie blanche: treatment with low-dose heparin. Arch Dermatol 122: 855–856, 1986.PubMedGoogle Scholar
  297. 281.
    Purcell SM, Hayes TJ: Nifedipine treatment of idiopathic atrophie blanche. J Am Acad Dermatol 14: 851–854, 1986.PubMedGoogle Scholar
  298. 282.
    Katz SI, Gallin JI, Hertz KC, et al.: Erythema elevatum diutinum: Skin and systemic manifestations, immunologic studies, and successful treatment with dapsone. Medicine 56: 443–455, 1977.PubMedGoogle Scholar
  299. 283.
    McNeely MC, Jorizzo JL, Solomon AR, Peltier FA: Erythema elevatum diutinum. Clin Rheumatol Pract, pp. 17–20, January/February 1985.Google Scholar
  300. 284.
    Rakover Y, Adar H, Tal I, et al.: Behcet disease: long-term follow-up of three children and review of the literature. Pediatrics 83: 986–992, 1989.PubMedGoogle Scholar
  301. 285.
    Plotkin GR, Calabro JJ, O’Duffy JD (eds.) Behcet’s Disease: A Contemporary Synopsis. Futura Publishing Company, Mount Kisco, NY, 1988.Google Scholar
  302. 286.
    Bartlett ST, McCarthy WJ, Palmer AS: Multiple aneurysms in Behcet’s disease. Arch Surg 123: 1004–1008, 1988.PubMedGoogle Scholar
  303. 287.
    Fukuda Y, Sakuma Y, Sumita M: Pathologic studies of vascular changes in Behcet’s disease. In Shiokawa, Y (ed.) Vascular Lesions of Collagen Diseases and Related Conditions. University Park Press, Baltimore, 1977, pp. 212–225.Google Scholar
  304. 288.
    Murakami T: Pathologic changes in the large blood vessels caused by Behcet’s disease, especially by neuro-Behcet’s disease. Bull Rheum Dis: S29: 229–235, 1978.Google Scholar
  305. 289.
    Lang BA, Laxer RM, Thorner P, et al.: Pediatric onset of Behcet’s syndrome with myositis: case report and literature review illustrating unusual features. Arthritis Rheum 33:418–425, 1990. (see also correspondence 34: 791, 1991 ).Google Scholar
  306. 290.
    Ammann AJ, Johnson A, Fyfe GA, et al.: Behcet’s syndrome. J Pediatr 107: 41–43, 1985.PubMedGoogle Scholar
  307. 291.
    Hamuryudan V, Yurdakul S, Ozbakir F: Monozygotic twins concordant for Behcet’s syndrome. Arthritis Rheum 34: 1071–1072, 1991.PubMedGoogle Scholar
  308. 292.
    Lebwohl O, Forde KA, Berdon WE, et al.: Ulcerative esophagitis and colitis in a pediatric patient with Behcet’s syndrome: Response to steroid therapy. Am J Gastroenterol 68: 550–555, 1977.PubMedGoogle Scholar
  309. 293.
    Vlymen WJ, Moskowitz PS: Roentgenographic manifestations of esophageal and intestinal involvement in Behcet’s disease in children. Pediatr Radiol 10: 193–196, 1981.PubMedGoogle Scholar
  310. 294.
    Mori S, Yoshihira A, Kawamura H, et al.: Esophageal involvement in Behcet’s Disease. Am J Gastroenterol 78: 548–553, 1983.PubMedGoogle Scholar
  311. 295.
    Kataora S, Hirose G, Tsukada K: Brain stem type neuro-Behcet’s syndrome: Correlation of enhanced CT scans and MRI during the acute and chronic stage of the illness. Neuroradiology 31: 258–262, 1989.Google Scholar
  312. 295a.
    Al-Kawi MS, Bohlega S, Banna M: MRI findings in neuro-Behcet’s disease. Neurology 41: 405–408, 1991.PubMedGoogle Scholar
  313. 296.
    Yurdakul S, Yazici H, Tuzun Y, et al.: The arthritis of Behcet’s disease: a prospective study. Ann Rheum Dis 42: 505–515, 1983.PubMedGoogle Scholar
  314. 297.
    Zelenski JD, Capraro JA, Holden D, Calabrese LH: Central nervous system vasculitis in Behcet’s syndrome: angiographic improvement after therapy cytotoxic agents. Arthritis Rheum 32: 217–220, 1989.PubMedGoogle Scholar
  315. 298.
    Harper CM, O’Neill BP, O’Duffy JD, Forbes GS: Intracranial hypertension in Behcet’s disease: demonstration of sinus occlusion with use of digital subtraction angiography. Mayo Clin Proc 60: 419–422, 1985.PubMedGoogle Scholar
  316. 299.
    Weschsler B, Bousser MG, Huong Du LT, et al.: Cerebral venous sinus thrombosis in Behcet’s disease. Mayo Clin Proc 60: 891–892, 1985.Google Scholar
  317. 300.
    Bowles CA, Nelson AM, Hammill SC, O’Duffy JD: Cardiac involvement in Behcet’s disease. Arthritis Rheum 28: 345–348, 1985.PubMedGoogle Scholar
  318. 301.
    Stricker H, Malinverni R: Multiple, large aneurysms of pulmonary arteries in Behcet’s disease: clinical remission and radiologic resolution after corticosteriod therapy. Arch Intern Med 149: 925–927, 1989.PubMedGoogle Scholar
  319. 302.
    Mizushima Y, Matsumura N: Chemotaxis of leukocytes and colchicine treatment in Behcet’s disease. J Rheumatol 6: 108–110, 1979.Google Scholar
  320. 303.
    Jorlzzo JL, Solomon AR, Zanolli MD, Leshin B: Neutrophilic vascular reactions. J Am Acad Dermatol 19: 983–1005, 1988.Google Scholar
  321. 304.
    Tafi L, Matucci-Cerinic M, Falcini F, et al.: Colchicine treatment of Behcet’s disease in children. Arthritis Rheum 30: 1435, 1987.PubMedGoogle Scholar
  322. 305.
    O’Duffy JD: Behcet’s Syndrome. N Engl J Med 322: 326–328, 1990.PubMedGoogle Scholar
  323. 306.
    Fam AG, Siminovitch KA, Carette S, From L: Case report: neonatal Behcet’s syndrome in an infant of a mother with the disease. Ann Rheum Dis 40: 509–512, 1981.PubMedGoogle Scholar
  324. 307.
    Cheson BD, Bluming AZ, Alroy J: Cogan’s syndrome: A systemic vasculitis. Am J Med 60: 549–555, 1976.PubMedGoogle Scholar
  325. 308.
    Kundell SP, Ochs HD: Cogan’s syndrome in childhood. J Pediatr 97: 96–98, 1980.PubMedGoogle Scholar
  326. 309.
    Haynes BF, Kaiser-Kupfer MI, Mason P, et al.: Cogan’s syndrome: studies in thirteen patients, long-term follow-up, and a review of the literature. Medicine 59: 426–441, 1980.PubMedGoogle Scholar
  327. 310.
    Haynes BF, Pikus A, Kaiser-Kupfer M, et al.: Successful treatment of sudden hearing loss in Cogan’s syndrome with corticosteroids. Arthritis Rheum 24: 501–503, 1981.PubMedGoogle Scholar
  328. 311.
    Allen NB, Cox C, Cobo M, et al.: Use of immunosuppressive agents in the treatment of severe ocular and vascular manifestations of Cogan’s syndrome. Am J Med 88: 296–301, 1990.PubMedGoogle Scholar
  329. 312.
    Jacobs JC: Arthritis as a manifestation of connective tissue disease. In Moore TD (ed.) Arthritis in Childhood: Report of the Eightieth Ross Conference on Pediatric Research. Ross Laboratories Columbus, Ohio, 1981, pp. 18–23.Google Scholar
  330. 313.
    Case Reports of the Massachusetts General Hospital. Case no. 44–1980. N Engl J Med 303: 1103–1111, 1980.Google Scholar
  331. 314.
    Su WP, Schroeter AL, Lee DA, et al.: Clinical and histologic findings in Degos syndrome (malignant atrophic papulosis). Cutis 35: 131–138, 1985.PubMedGoogle Scholar
  332. 315.
    Lie JT, Gordon LP, Titus JL: Juvenile temporal arteritis. JAMA 234: 496–499, 1975.Google Scholar
  333. 316.
    Golden GT, Fox JW, Williams GS, et al.: Traumatic aneurysm of the superficial temporal artery. JAMA 234: 517–518, 1975.Google Scholar
  334. 317.
    Huston KA, Combs JJ, Lie JT, Giuliani ER: Left atrial myxoma simulating peripheral vasculitis. Mayo Clin Proc 53: 752–756, 1978.PubMedGoogle Scholar
  335. 318.
    Byrd WE, Matthews OP, Hunt RE: Left atrial myxoma presenting as a systemic vasculitis. Arthritis Rheum 23: 240–243, 1980.PubMedGoogle Scholar
  336. 319.
    Fitzpatrick AP, Lanham JG, Doyle DV: Cardiac tumours simulating collagen vascular disease. Br Heart J 55: 592–595, 1986.PubMedGoogle Scholar
  337. 320.
    Boers GHJ, Smals AGH, Trijbels FJM, et al.: Heterozygosity for homocystinuria in premature peripheral and cerebral occlusive areterial disease. N Engl J Med 313: 709–715, 1985.PubMedGoogle Scholar
  338. 321.
    Shih VE, Abroms IF, Johnson JL, et al.: Sulfite oxidase deficiency. N Engl J Med 297: 1022–1028, 1977.PubMedGoogle Scholar
  339. 322.
    Radtke WE, Kazmier FJ, Rutherford BD: Cardiovascular complications of pheochromocytoma crisis. Am J Cardiol 35: 701–705, 1975.PubMedGoogle Scholar
  340. 323.
    Sisson JC, Frager MS, Valk TW, et al.: Scintigraphic localization of pheochromocytoma. N Engl J Med 305: 12–17, 1981.PubMedGoogle Scholar
  341. 324.
    Ambruso DR, Jacobson LJ, Hathaway WE: Inherited antithrombin-III deficiency and cerebral thrombosis in a child. Pediatrics 65: 125–131, 1980.PubMedGoogle Scholar
  342. 325.
    Lechat PH, Mas JL, Lascault G, et al.: Prevalence of patient foramen ovale in patients with stroke. New Engl J Med 318: 1148–1152, 1988.PubMedGoogle Scholar
  343. 326.
    Olsen ML, O’Connor S, Arnett FC, et al.: Autoantibodies and rheumatic disorders in a neurology inpatient population: a prospective study. Am J Med 90: 479–488, 1991.PubMedGoogle Scholar
  344. 327.
    Roddy SM, Giang DW: Antiphospholipid antibodies and stroke in an infant. Pediatrics 87: 933–935, 1991.PubMedGoogle Scholar
  345. 328.
    Case records of the Massachusetts General Hospital. Case 37–1988. N Engl J Med 319: 699–712, 1988.Google Scholar
  346. 329.
    Driscoll PF, Larsen PD, Gruber AB: MELAS syndrome involving a mother and two children. Arch Neurol 44: 971–973, 1987.PubMedGoogle Scholar
  347. 330.
    Ohtoh T, Iwasaki Y, Namiki T, et al.: Hemodynamic characteristics of the vertebrobasilar system in moyamoya disease. Hum Pathol 19: 465–470, 1988.PubMedGoogle Scholar
  348. 331.
    Carlson CB, Harvey FH, Loop J: Progressive alternating hemiplegia in early childhood with basal artery stenosis and telangiectasra (Moyamoya syndrome). Neurology 23: 734–744, 1973.PubMedGoogle Scholar
  349. 332.
    Goldberg HJ: Moyamoya associated with peripheral vascular occlusive disease. Arch Dis Child 49: 964–966, 1974.Google Scholar
  350. 333.
    Provost TT, Moses H, Morris EL, et al.: Cerebral vasculopathy associated with collateralization resembling Moya Moya phenomenon and with anti-Ro/SS-A and anti-La/SS-B antibodies. Arthritis Rheum 34: 1052–1055, 1991.PubMedGoogle Scholar
  351. 334.
    Goldie W: Headache, hemiparesis, and hemianopsia in a five-year-old. Hosp Pract 17: 200–201, 1982.Google Scholar
  352. 335.
    Loughlin GM, Taussig LM, Murphy SA, et al.: Immune-complex-mediated glomerulonephritis and pulmonary hemorrhage simulating Goodpasture’s syndrome. J Pediatr 93: 181–184, 1978.PubMedGoogle Scholar
  353. 336.
    Mark EJ, Ramirez JF: Pulmonary capillaritis and hemorrhage in patients with systemic vasulitis. Arch Pathol Lab Med 109: 413–418, 1985.PubMedGoogle Scholar
  354. 337.
    Myers JL, Katzenstein A-LA: Microangiitis in lupus-induced pulmonary hemorrhage. Am J Clin Pathol 85: 552, 1986.PubMedGoogle Scholar
  355. 338.
    Urizar RE, McGoldrick MD, Cerda J: Pulmonary-renal syndrome. Its Clinicopathologic approach in 1991. NYS J Med 91: 212–221, 1991.Google Scholar
  356. 339.
    Davis JP, Chesney PJ, Wand PJ, et al.: Toxic-shock syndrome. Epidemiologic features, recurrence, risk factors, and prevention. N Engl J Med 303: 1429–1435, 1980.PubMedGoogle Scholar
  357. 340.
    Shands KN, Schmid MD, Dan BB, et al.: Toxic-shock syndrome in menstruating women. Association with tampon use and Staphylococcus aureus and clinical features in 52 cases. N Engl J Med 303: 1436–1442, 1980.PubMedGoogle Scholar
  358. 341.
    Chesney PJ, Davis JP, Purdy WK, et al.: Clinical manifestations of toxic shock syndrome. JAMA 246: 741–748, 1981.Google Scholar
  359. 342.
    Reingold AL, Shands KN, Dan BB, et al.: Toxic-shock syndrome not associated with menstruation. A review of 54 cases. Lancet 1: 1–4, 1982.PubMedGoogle Scholar
  360. 343.
    Buchdahl R, Levin M, Wilkins B, et al.: Toxic shock syndrome. Arch Dis Child 60: 563–567, 1985.PubMedGoogle Scholar
  361. 344.
    MacDonald KL, Osterholm MT, Hedberg CW, et al.: Toxic shock syndrome. A newly recognized complication of influenza and influenzalike illness. JAMA 257: 1053–1058, 1987.Google Scholar
  362. 345.
    Resnick SD: Toxic shock syndrome: recent developments in pathogenesis. J Pediatr 116: 321–328, 1990.PubMedGoogle Scholar
  363. 346.
    Barry W, Hudgins L, Donta ST, Pesanti EL: Intravenous immunoglobulin therapy for toxic shock syndrome. JAMA 267: 3315–3316, 1992.Google Scholar
  364. 347.
    Stevens DL, Tanner MH, Winship J, et al.: Severe group a streptococcal infections associated with a toxic shock-like syndrome and scarlet fever toxin A. N Engl J Med 321: 1–7, 1989.PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1993

Authors and Affiliations

  • Jerry C. Jacobs
    • 1
  1. 1.Section of Pediatric Rheumatology and the Regional Arthritis Program (RAP-4-Kids)Columbia-Presbyterian Medical CenterNew YorkUSA

Personalised recommendations